期刊文献+

双源CT血管重建对胰腺癌可切除性的评估作用 被引量:8

Effect of dual source CT vascular-reconstruction evaluation on the resectability of pancreatic carcinoma
暂未订购
导出
摘要 目的探讨胰腺癌术前双源CT血管重建评估对手术可切除性及根治性切除率(R0切除)的影响。方法随机抽取我院2011年1月至2014年12月间行双源CT平扫+增强+血管重建后手术治疗的胰腺癌患者49例,设定为重建组(胰头癌29例,胰体尾癌20例);另随机选取我院2007年1月至2010年12月间行常规CT平扫+增强后手术治疗的55例胰腺癌患者设定为非重建组(胰头癌33例,胰体尾癌22例),分析两组的可切除率(所有入组病例均已排除远端转移和周围脏器浸润);对两组手术切除的患者进一步行R0切除率比较。结果就胰头癌而言,重建组手术切除率和阴性切缘率分别为82.8%(24/29)和87.5%(21/24),均显著高于非重建组63.6%(21/33)和76.2%(16/21)(x^2=22.41和15.73,P=0.001和0.002);对于胰体尾癌,重建组手术切除率和R0切除率分别为90%(18/20)和88.9%(16/18),均显著高于非重建组77.3%(17/22)和76.5%(13/17)(x2=13.1和12.56,P=0.004和0.01)。结论术前双源CT血管重建能够显著提高胰腺癌手术切除率和R0切除率,值得进一步临床推广。 Objective To investigate the significance of preoperative dual source computed tomography(DSCT) vascular-reconstruction on the resectability and radicality of pancreatectomy. Methods In present study,49 pancreatic carcinoma cases received preoperative assessment of dual-source CT plain plus enhanced scan and vascular reconstruction in our hospital between Jan. 2011 and Dec. 2014 were randomly assigned to Reconstruction group(29 cases of pancreatic head carcinoma and 20 cases of pancreatic body and tail cancer), another 55 pancreatic carcinoma patients received preoperative assessment of conventional 16-slice CT plain plus enhanced scan between Jan. 2007 to Dec. 2010 were randomly assigned to Non-reconstruction group(33 cases of pancreatic head carcinoma and 22 cases of pancreatic body and tail cancer). The ratios of resectability and consequent negative cut margin proportion were analyzed between two groups. Results For pancreatic head carcinoma, the resectability and negative cut margin proportion in Reconstrction group were 82.8%(24/29) and 87.5%(21/24), both significantly higher than those in Non-reconstruction group 63.6%(21/33) and 76.2%(16/21)(χ2=22.41 and 15.73, P=0.001 and 0.002). Similarly results were found in patients with pancreatic body and tail cancer, the resectability and negative cut margin proportion in Reconstruction group were 90%(18/20) and 88.9%(16/18), which were evidently lower than those in Non-reconstruction group 77.3%(17/22) and 76.5%(13/17)(χ2=13.1 and 12.56, P=0.004 and0.01). Conclusion Our results demonstrate that preoperative DSCT vascular-reconstruction can effectively improve the resectability and negative cut margin proportion of pancreatectomy, and deserves further application.
出处 《肝胆胰外科杂志》 CAS 2016年第5期378-381,385,共5页 Journal of Hepatopancreatobiliary Surgery
关键词 胰腺癌 双源CT 血管重建 手术可切除性 pancreatic carcinoma dual-source computed tomography(DSCT) vascular-reconstruction resectability
  • 相关文献

参考文献11

  • 1WANG S H, SUN Y F, LIU Y, et a. CT contrast enhancement correlates with pathological grade and microvessel density of pancreatic cancer tissues [J]. Int J CIin Exp Pathol, 2015, 8(5): 5443-5449.
  • 2洪德飞,彭淑牖,沈国樑,成剑,王知非,张军港,黄东胜.全胰腺系膜切除理念应用于胰头癌根治术的初步体会[J].中华普通外科杂志,2014,29(5):344-347. 被引量:23
  • 3KLAUSS M, STILLER W, FRITZ F, et al. Computed tomog- raphy perfusion analysis of pancreatic carcinoma [J]. J Corn- put Assist Tomogr, 2012, 36(2): 237-242.
  • 4赵玉沛.作好胰头癌外科治疗的基本策略与思考[J].中华肝胆外科杂志,2011,17(1):1-4. 被引量:16
  • 5YANG M J, LI S, LIU Y G, et al. Common and unusual CT and MRI manifestations of pancreatic adenocarcinoma: a pic- torial review [J]. Quant Imaging Med Surg, 2013, 3(2): 113- 120.
  • 6YU Y, GUO M, HAN X. Comparison of multi-slice computed tomographic angiography and dual-source computed tomo- graphic angiography in resectability evaluation of pancreaticcarcinoma [J]. Cell Biochem Biophys, 2014, 70(2): 1351- 1356.
  • 7刁同进,赵晓东,陈新,庄兴俊,袁伟升.胰头癌的外科手术综合治疗143例临床分析[J].肝胆胰外科杂志,2013,25(5):376-380. 被引量:19
  • 8FRELLESEN C, FMESSLER F, HARDIE A D, et al. Dual- energy CT of the pancreas: improved carcinoma-to-pancreas contrast with a noise-optimized monoenergetic reconstruction algorithm [J]. Eur J Radiol, 2015, 84(11): 2052-2058.
  • 9杨冲,王博,李永峰,勾善淼,王春友,吴河水.不合并消化道梗阻的晚期胰头癌441例临床诊治分析[J].中华普通外科杂志,2013,28(5):347-350. 被引量:2
  • 10P1ETRYGA J A, MORGAN D E. Morgan. Imaging preopera- tively for pancreatic adenocarcinoma [J]. J Gastrointest On- col, 2015, 6(4): 343-357.

二级参考文献52

  • 1SD Mansfield,O Barakat,RM Charnley,BC Jaques,CB O'Suilleabhain,PJ Atherton,D Manas.Management of hilar cholangiocarcinoma in the North of England: Pathology, treatment, and outcome[J].World Journal of Gastroenterology,2005,11(48):7625-7630. 被引量:38
  • 2Yasuji Seyama,Masatoshi Makuuchi.Current surgical treatment for bile duct cancer[J].World Journal of Gastroenterology,2007,13(10):1505-1515. 被引量:75
  • 3Algül H,Schmid RM.Pancreatic cancer:a plea for good and comprehensive morphological studies.Eur J Gastroenterol Hepatol,2008,20:713-715.
  • 4Borja-Cacho D,Jensen EH,Saluja AK,et al.Molecular targeted therapies for pancreatic cancer.Am J Surg,2008,196:430-441.
  • 5Li J,Wientjes MG,Au JL.Pancreatic cancer:pathobiology,treatment options,and drug delivery.AAPSJ,2010,12:223-232.
  • 6Lee MK,Dinorcia J,Reavey PL,et al.Pancreaticoduodenectomy can be performed safely in patients aged 80 years and older.J Gastrointest Surg,2010,14:1838-1846.
  • 7Khan S,Sclabas G,lombardo KR,et al.Pancreatoduodenectomy for ductal adenocarcinoma in the very elderly; is it safe and justified? J Gastrointest Surg,2010,14:1826-1831.
  • 8Oliverius M,Kala Z,Varga M,et al.Radical surgery for pancreatic malignancy in the elderly.Pancreatology,2010,10:499-502.
  • 9Khan S,Sclabas G,Reid-Lombardo K,et al.Does body mass index/morbid obesity influence outcome in patients who undergo pancreatoduodenectomy for pancreatic adenocarcinoma? J Gastrointest Surg,2010,14:1820-1825.
  • 10Raptis DA,Fessas C,Belasyse-Smith P,et al.Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer.Surgeon,2010,8:239-246.

共引文献54

同被引文献56

引证文献8

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部